Azenta, Inc. (AZTA)
31.45
+0.27
(+0.87%)
USD |
NASDAQ |
Sep 04, 15:00
Azenta Cash from Investing (Quarterly) : 4.724M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.724M |
| March 31, 2026 | -114.75M |
| December 31, 2025 | 36.77M |
| September 30, 2025 | 0.826M |
| June 30, 2025 | -29.70M |
| March 31, 2025 | -138.67M |
| December 31, 2024 | 77.09M |
| September 30, 2024 | 198.01M |
| June 30, 2024 | 199.74M |
| March 31, 2024 | -272.03M |
| December 31, 2023 | 99.02M |
| September 30, 2023 | 102.49M |
| June 30, 2023 | 214.37M |
| March 31, 2023 | 58.17M |
| December 31, 2022 | 56.36M |
| September 30, 2022 | -374.48M |
| June 30, 2022 | 31.87M |
| March 31, 2022 | 1.827B |
| December 31, 2021 | -18.42M |
| September 30, 2021 | -17.52M |
| June 30, 2021 | -101.45M |
| March 31, 2021 | 2.909M |
| December 31, 2020 | -30.29M |
| September 30, 2020 | -10.19M |
| June 30, 2020 | -8.515M |
| Date | Value |
|---|---|
| March 31, 2020 | -17.27M |
| December 31, 2019 | 13.23M |
| September 30, 2019 | 619.39M |
| June 30, 2019 | -5.872M |
| March 31, 2019 | -3.61M |
| December 31, 2018 | -398.60M |
| September 30, 2018 | -6.509M |
| June 30, 2018 | -22.04M |
| March 31, 2018 | -25.57M |
| December 31, 2017 | -94.35M |
| September 30, 2017 | -45.20M |
| June 30, 2017 | 1.676M |
| March 31, 2017 | -1.385M |
| December 31, 2016 | -9.284M |
| September 30, 2016 | -0.458M |
| June 30, 2016 | -4.325M |
| March 31, 2016 | -0.779M |
| December 31, 2015 | -5.312M |
| September 30, 2015 | -4.965M |
| June 30, 2015 | -3.66M |
| March 31, 2015 | 0.56M |
| December 31, 2014 | -9.572M |
| September 30, 2014 | -23.57M |
| June 30, 2014 | 29.30M |
| March 31, 2014 | -15.20M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Agilent Technologies, Inc. | -1.032B |
| Bio-Rad Laboratories, Inc. | -66.70M |
| Bruker Corp. | -25.30M |
| Danaher Corp. | -10.15B |
| Harvard Bioscience, Inc. | -0.916M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.445M |
| Cash from Financing (Quarterly) | -50.32M |
| Free Cash Flow | 9.881M |
| Free Cash Flow Per Share (Quarterly) | -0.1147 |
| Free Cash Flow to Equity (Quarterly) | -3.45M |
| Free Cash Flow to Firm (Quarterly) | -5.194M |
| Free Cash Flow Yield | 0.69% |